Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bupropion for ADHD in Adolescents With Substance Use Disorder

NCT00936299 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT00936299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00936299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bupropion for ADHD in Adolescents With Substance Use Disorder
Lead sponsor
University of Colorado, Denver
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2009
Completion date
May 31, 2013
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder, cannabis use disorder, nicotine dependence